Strategies may include inhibiting immunosuppressive cytokines (e.g., TGF-β), delivering immunomodulatory cytokines (e.g., GM-CSF), and targeting angiogenesis to enhance the accumulation of tumor-infiltrating lymphocytes. This evidence concerns the gene CSF2 and neoplasm.